NL-OMON33787已完成2 期
Pyridostigmine: using a cholinesterase inhibitor to activate the cholinergic anti-inflammatory pathway in patients with CRPS-1 - Anti-inflammatory effects of Pyridostigmine in CRPS-1 patients.
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •CRPS-1 according to Veldman criteria
- •Unsatisfactory results of convential therapy
- •Minimum age 18
排除标准
- •Medical condition of the contralateral extrimity
- •cardiac problems
- •hyperthyroidism
- •kreatinin > 100
- •severe psychiatric disorder
- •active malignant disease
- •other chronic pain syndrome
研究者
相似试验
进行中（未招募）
不适用
Pyridostigmine: using a cholinesterase inhibitor to activate the cholinergic anti-inflammatory pathway in patients with CRPS-1 - Pyridostigmine trialPatients with CRPS-1.EUCTR2009-010758-36-NLVU University Medical Center10
尚未招募
不适用
The effect of Pyridostigmine on patients with CRPS-1.complex regional pain syndrome, neuropathic pain, neurogenic inflammation,NL-OMON20521TREND10
进行中（未招募）
3 期
The use of Pyridostigmine bromide in the treatment of fatigue secondary to COVID-19Post-Viral Fatigue SyndromeCOVID-19C01.925RBR-107j3g4vniversidade Federal Fluminense
招募中
3 期
Effect of pyridostigmine in stroke-related dysphagiaIRCT20230520058232N1Sanandaj University of Medical Sciences60
已完成
1 期
AchE Inhibitor and InsulinDiabetes MellitusNCT03063515University of Miami12